听力损失与双重感觉损失和死亡率的关联:对26项观察性研究共1 213 756名参与者的系统评价、Meta分析与Meta回归
该系统评价纳入14项回顾性和12项前瞻性观察性研究共1 213 756名参与者,发现听力损失与全因死亡率(HR 1.13)和心血管死亡率(HR 1.28)超额风险相关,双重感觉损失关联更强(全因HR 1.40,心血管HR 1.86),总体证据质量中等。
要点
- 听力损失与全因死亡率超额风险相关(HR 1.13,95%CI 1.07-1.19)。
- 双重感觉损失与全因死亡率超额风险相关(HR 1.40,95%CI 1.30-1.51)。
- 双重感觉损失与心血管死亡率超额风险相关(HR 1.86,95%CI 1.31-2.65)。
核心结论
- 听力损失和双重感觉损失与全因死亡率和心血管死亡率超额风险相关。
- 照顾听力损失患者的医生应考虑其与整体健康和长寿的相关性。
研究设计与样本
- 系统评价、Meta分析与Meta回归,检索PubMed、Embase和Cochrane Library自建库至2021年6月18日。
- 纳入14项回顾性和12项前瞻性观察性研究,共1 213 756名参与者,来自3220条记录。
- 两名盲法评价者选取报告成人(18岁及以上)听力损失或双重感觉损失与任何死亡率估计关联的观察性或干预性研究。
- 采用混合效应模型合并最大调整估计值,使用I2衡量异质性,采用GRADE框架评估证据质量。
主要发现
- 听力损失与全因死亡率超额风险相关(HR 1.13;95%CI 1.07-1.19;I2=77%;n=21;95%预测区间0.93-1.37)。
- 听力损失与心血管死亡率超额风险相关(HR 1.28;95%CI 1.10-1.50;I2=60%;n=6;95%预测区间0.84-1.96)。
- 双重感觉损失与全因死亡率超额风险相关(HR 1.40;95%CI 1.30-1.51;I2=34%;n=10;95%预测区间1.18-1.66)。
- 双重感觉损失与心血管死亡率超额风险相关(HR 1.86;95%CI 1.31-2.65;I2=0%;n=2)。
- 预设Meta回归充分解释异质性,随访时间越长合并关联越弱,残余异质性低(29%);听力测定研究中听力损失每增加30 dB,HR翻倍。
关键数值与推荐
- 听力损失与全因死亡率关联的HR为1.13(95%CI 1.07-1.19)。
- 双重感觉损失与全因死亡率关联的HR为1.40(95%CI 1.30-1.51)。
- 双重感觉损失与心血管死亡率关联的HR为1.86(95%CI 1.31-2.65)。
- 总体证据质量中等。
临床怎么用
- 照顾听力损失患者的医生应考虑其与整体健康和长寿的相关性。
局限性
- 听力损失与全因死亡率关联的95%预测区间为0.93-1.37。
- 听力损失与心血管死亡率关联的95%预测区间为0.84-1.96。
- 与事故/伤害、癌症和卒中死亡率的关联尚无定论,仅1至3项研究。
- 总体证据质量中等。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hearing loss (HL) and dual sensory loss (DSL) are prevalent, disabling, and associated with numerous age-related health conditions, including dementia and frailty. To date, no evidence-based summary of their mortality risk is available. OBJECTIVE: To clarify the epidemiological associations between HL/DSL and mortality. DATA SOURCES: PubMed, Embase, and Cochrane Library, from inception until June 18, 2021. STUDY SELECTION: Two blinded reviewers selected observational or interventional studies, published as full-length English articles in peer-reviewed journals, that reported the presence or severity of HL or DSL (ie, comorbid HL and vision loss), whether objectively measured or self-reported, in association with any mortality estimate, among adults 18 years and older. DATA EXTRACTION AND SYNTHESIS: Two reviewers extracted data and evaluated study bias using the Newcastle-Ottawa Scale, following Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA)/Meta-analysis of Observational Studies in Epidemiology (MOOSE) guidelines and a PROSPERO-registered protocol. The analysis pooled maximally adjusted estimates using mixed-effects models, measured heterogeneity using I2, investigated sources of heterogeneity using meta-regression and subgroup meta-analyses, examined and adjusted for publication bias, performed influence and cumulative meta-analyses, and assessed evidence quality using the Grading of Recommendations, Assessment, Development and Evaluations (GRADE) framework. MAIN OUTCOMES AND MEASURES: Hazard ratios (HRs) for all-cause, cardiovascular, or other mortality estimates. RESULTS: This review included 14 retrospective and 12 prospective observational studies (1 213 756 participants) from 3220 records. Risk of bias was low to moderate; exclusion of 3 high-risk studies did not alter conclusions. Hearing loss was associated with excess all-cause mortality (HR, 1.13; 95% CI, 1.07-1.19; I2 = 77%; n = 21; 95% prediction interval [PI], 0.93-1.37) and cardiovascular mortality (HR, 1.28; 95% CI, 1.10-1.50; I2 = 60%; n = 6; 95% PI, 0.84-1.96), while DSL was associated with larger excess risks (all-cause: HR, 1.40; 95% CI, 1.30-1.51; I2 = 34%; n = 10; 95% PI, 1.18-1.66; cardiovascular: HR, 1.86; 95% CI, 1.31-2.65; I2 = 0%; n = 2), after adjustment for demographics and comorbidities. Prespecified meta-regression sufficiently explained heterogeneity, with longer follow-up duration weakening the pooled association, leaving low (29%) residual heterogeneity. Meta-regression among audiometric studies showed a dose-response association (doubling of HR per 30-dB increase in HL). Self-reported and audiometric effect sizes were similar, with lower heterogeneity in the latter. Associations were robust to trim-and-fill adjustment for publication bias and single-study influence and cumulative meta-analyses. Associations with accident/injury, cancer, and stroke mortality were inconclusive, with only 1 to 3 studies. Overall evidence quality was moderate. CONCLUSIONS AND RELEVANCE: In this systematic review and meta-analysis, HL and DSL were associated with excess all-cause and cardiovascular mortality. Physicians caring for patients with HL should consider its relevance to general health and longevity.
引用
- Tan BKJ, Ng FYC, Song HJJMD, et al. Associations of Hearing Loss and Dual Sensory Loss With Mortality: A Systematic Review, Meta-analysis, and Meta-regression of 26 Observational Studies With 1 213 756 Participants. JAMA Otolaryngol Head Neck Surg. 2022. PMID: 34967895. doi:10.1001/jamaoto.2021.3767
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。